Osaic Holdings’s OnKure Therapeutics OKUR Stock Holding History

Osaic Holdings’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$372	Sell	90 -19	-17%	-$59	﹤0.01%	7486
2025 Q4	$316	Buy	109 +9	+9%	+$27	﹤0.01%	7512
2025 Q3	$275	Hold	100	–	–	﹤0.01%	7655
2025 Q2	$239	Buy	+100	New	+$262	﹤0.01%	7476
2025 Q1	–	Sell	-152	Closed	-$1.31K	–	7768
2024 Q4	$1.31K	Sell	152 -1	-0.7%	-$15	﹤0.01%	6750
2024 Q3	$2.59K	Buy	+153	New	+$2.26K	﹤0.01%	6503
2024 Q2	–	Sell	-4	Closed	-$68	–	7655
2024 Q1	$68	Hold	4	–	–	﹤0.01%	7066
2023 Q4	$66	Sell	4 -6	-60%	-$374	﹤0.01%	7146
2023 Q3	$762	Buy	+10	New	+$680	﹤0.01%	6901

Other funds holding OKUR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Osaic Holdings's OKUR Position: Q1 2026 in Review

Osaic Holdings reduced its OnKure Therapeutics (OKUR) stake by 17% in Q1 2026, selling an estimated $59 and leaving 90 shares worth $372. The position accounts for ﹤0.01% of the portfolio, ranked #7486.

Osaic Holdings first reported a position in OKUR in Q3 2023 and has held it in 9 quarters since. The position peaked at $2.59K in Q3 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

Osaic Holdings held 90 shares of OnKure Therapeutics worth $372 as of Q1 2026.
Osaic Holdings sold 19 OnKure Therapeutics shares in Q1 2026, an estimated $59.
OnKure Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7486 holding.
Osaic Holdings first reported a position in OnKure Therapeutics in Q3 2023 and has held it in 9 quarters since.
Osaic Holdings's OnKure Therapeutics position peaked at $2.59K in Q3 2024.
51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.